Gluconeogenesis is primarily responsible for maintaining blood glucose levels during periods of fasting or starvation, when the body's glycogen stores are depleted and there is no dietary intake of carbohydrates.

The liver is the primary site of gluconeogenesis, accounting for approximately 80% of glucose production in the body.

The main precursors for gluconeogenesis are lactate, glycerol, alanine, and glutamine, which are derived from the breakdown of proteins, fats, and lactate.

Gluconeogenesis is stimulated by several hormones, including insulin, glucagon, epinephrine, and cortisol.

The first step in gluconeogenesis is the conversion of pyruvate to oxaloacetate, which is catalyzed by the enzyme pyruvate carboxylase.

The final step in gluconeogenesis is the conversion of fructose-1,6-bisphosphate to glucose-6-phosphate, which is catalyzed by the enzyme glucose-6-phosphatase.

The net energy yield of gluconeogenesis is 6 ATP molecules per molecule of glucose produced.

Gluconeogenesis has several physiological significances, including maintaining blood glucose levels during fasting or starvation, providing energy for muscle contraction, synthesizing glycogen for storage, and producing glucose for the brain.

Impaired gluconeogenesis can lead to several disorders, including type 1 diabetes, type 2 diabetes, hypoglycemia, and ketosis.

Gluconeogenesis contributes to the Cori cycle by converting lactate to glucose in the liver, converting glucose to lactate in skeletal muscle, transporting lactate from skeletal muscle to the liver, and transporting glucose from the liver to skeletal muscle.

Gluconeogenesis plays a crucial role in regulating blood glucose levels by helping maintain blood glucose levels within a narrow range, preventing hypoglycemia, preventing hyperglycemia, and helping the body adapt to changes in dietary carbohydrate intake.

The rate of gluconeogenesis can be influenced by hormonal signals, substrate availability, and the energy status of the body.

Gluconeogenesis contributes to the overall energy metabolism of the body by providing a source of glucose for energy production, helping maintain blood glucose levels during fasting or starvation, helping spare glycogen stores, and helping prevent ketosis.

Targeting gluconeogenesis has potential therapeutic applications in the treatment of type 1 diabetes, type 2 diabetes, obesity, and non-alcoholic fatty liver disease.